ARTICLE | Clinical News
TransCon treprostinil: Phase I data
May 11, 2015 7:00 AM UTC
A Phase I trial showed that single ascending doses of TransCon treprostinil led to treatment-related injection site tolerability issues that Ascendis said did not meet the criteria defined in the targ...